Independent group finds new cholesterol ***** far too costly
Independent group finds new cholesterol ***** far too costly
(Reuters) - An independent **n-profit organization that evaluates clinical and cost effectiveness of new medicines said an**unced prices for a just-approved class of potent cholesterol lowering ***** were far too high, according to a draft report released on Tuesday.